AACR Names T-Cell ALL Researcher as a 2023 Next Gen Star

By Anastasia Tikhonova, PhD - Last Updated: May 9, 2023

Anastasia Tikhonova, PhD, was named a 2023 NextGen Star by the American Association for Cancer Research (AACR). Dr. Tikhonova, whose research is in T-cell acute lymphoblastic leukemia (ALL), talks about the honor of being awarded the title in this video interview.

Post Tags:AACR 2023

Study Finds Link Between Gut Health and Leukemia Risk

Melissa BadamoAcute Myeloid Leukemia | May 19, 2025

ADP-heptose in the intestines of older individuals accelerates the expansion of pre-leukemic blood cells.

Oncologists Are Resigning at Unprecedented Rates: Are Academic Medical Centers Ready to Respond?

Melissa BadamoAcute Lymphoblastic Leukemia | May 16, 2025

Studies have shown that oncologists are leaving the workforce at increasing rates in association with growing workloads.

LucyRx Expands Specialty Pharmacy Network to Remove Barriers in Cancer Care

Melissa BadamoAcute Lymphoblastic Leukemia | May 8, 2025

LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..

ASPHO Recognizes Pediatric Hematologist-Oncologists at Annual Meeting

Melissa BadamoPrint | May 7, 2025

The awards recognize early-, mid-, or senior-career experts who display excellence in the field.

Blazing a Trail in Ph-ALL: Chemotherapy-Free Options Gain Ground

Nichole TuckerAcute Lymphoblastic Leukemia | May 6, 2025

During The HemOnc Pulse Live! Nick Short, MD gave a presentation on unanswered questions in ALL.

AACR Names T-Cell ALL Researcher as a 2023 Next Gen Star

Related Posts